Anti-Hgf Igg1 Mab (Clinical Trials) Equipment
1 equipment items found
-
Manufactured by AVEO Pharmaceuticals, Inc.based in USA
Ficlatuzumab (formerly known as AV-299) is a potent hepatocyte growth factor (HGF) immunoglobulin G1 (IgG1) inhibitory antibody that binds to the HGF ligand with high affinity and specificity. HGF is the natural ligand of c-Met and blocking HGF inhibits signaling through the HGF/c-Met signaling ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you